WallStSmart

Coca-Cola European Partners PLC (CCEP)vsNu Skin Enterprises Inc (NUS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 1453% more annual revenue ($21.35B vs $1.38B). CCEP leads profitability with a 9.3% profit margin vs -15.7%. NUS appears more attractively valued with a PEG of 0.78. CCEP earns a higher WallStSmart Score of 49/100 (D+).

CCEP

Hold

49

out of 100

Grade: D+

Growth: 5.3Profit: 7.0Value: 4.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.59

NUS

Hold

47

out of 100

Grade: D+

Growth: 2.0Profit: 4.5Value: 7.7Quality: 7.5
Piotroski: 5/9Altman Z: 4.45
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CCEP.

NUSUndervalued (+53.3%)

Margin of Safety

+53.3%

Fair Value

$21.79

Current Price

$4.79

$17.00 discount

UndervaluedFair: $21.79Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP1 strengths · Avg: 10.0/10
Return on EquityProfitability
42.7%10/10

Every $100 of equity generates 43 in profit

NUS3 strengths · Avg: 9.3/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Altman Z-ScoreHealth
4.4510/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.788/10

Growing faster than its price suggests

Areas to Watch

CCEP4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
4.4%4/10

4.4% revenue growth

Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

Debt/EquityHealth
1.473/10

Elevated debt levels

PEG RatioValuation
3.142/10

Expensive relative to growth rate

NUS4 concerns · Avg: 2.5/10
Market CapQuality
$230.73M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
6.9%3/10

ROE of 6.9% — below average capital efficiency

Revenue GrowthGrowth
-17.1%2/10

Revenue declined 17.1%

EPS GrowthGrowth
-98.2%2/10

Earnings declined 98.2%

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on Return on Equity.

Bull Case : NUS

The strongest argument for NUS centers on Price/Book, Altman Z-Score, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.

Bear Case : CCEP

The primary concerns for CCEP are Revenue Growth, Altman Z-Score, Debt/Equity.

Bear Case : NUS

The primary concerns for NUS are Market Cap, Return on Equity, Revenue Growth.

Key Dynamics to Monitor

CCEP profiles as a value stock while NUS is a turnaround play — different risk/reward profiles.

NUS carries more volatility with a beta of 0.97 — expect wider price swings.

CCEP is growing revenue faster at 4.4% — sustainability is the question.

CCEP generates stronger free cash flow (604M), providing more financial flexibility.

Bottom Line

CCEP scores higher overall (49/100 vs 47/100). NUS offers better value entry with a 53.3% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Visit Website →

Nu Skin Enterprises Inc

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Nu Skin Enterprises, Inc. develops and distributes wellness and personal care products globally. The company is headquartered in Provo, Utah.

Visit Website →

Want to dig deeper into these stocks?